 | • レポートコード：20QY06-01860 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、ゴナドトロピン放出ホルモン作用物質薬のグローバル市場について種類別（ロイプロレリン、ゴセレリン、タルチレリン、ヒストレリン、その他）、用途別（病院、薬局、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ゴナドトロピン放出ホルモン作用物質薬市場の概要 ・世界の主要地域別ゴナドトロピン放出ホルモン作用物質薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のゴナドトロピン放出ホルモン作用物質薬市場規模2015-2026：種類別（ロイプロレリン、ゴセレリン、タルチレリン、ヒストレリン、その他） ・世界のゴナドトロピン放出ホルモン作用物質薬市場規模2015-2026：用途別（病院、薬局、その他） ・ゴナドトロピン放出ホルモン作用物質薬の北米市場規模2015-2020 ・ゴナドトロピン放出ホルモン作用物質薬のヨーロッパ市場規模2015-2020 ・ゴナドトロピン放出ホルモン作用物質薬の中国市場規模2015-2020 ・ゴナドトロピン放出ホルモン作用物質薬の日本市場規模2015-2020 ・ゴナドトロピン放出ホルモン作用物質薬の東南アジア市場規模2015-2020 ・ゴナドトロピン放出ホルモン作用物質薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （AbbVie、AstraZeneca、Ferring、TerSera Therapeutics、Takeda、LIVZON、Ipsen、Sanofi、Endo） ・ゴナドトロピン放出ホルモン作用物質薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・ゴナドトロピン放出ホルモン作用物質薬の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Gonadotropin-releasing Hormone Agonist Drugs market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Gonadotropin-releasing Hormone is a releasing hormone responsible for the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Gonadotropin-releasing Hormone Agonist Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Gonadotropin-releasing Hormone Agonist Drugs industry.
Based on our recent survey, we have several different scenarios about the Gonadotropin-releasing Hormone Agonist Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Gonadotropin-releasing Hormone Agonist Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Gonadotropin-releasing Hormone Agonist Drugs market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Gonadotropin-releasing Hormone Agonist Drugs market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Gonadotropin-releasing Hormone Agonist Drugs market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Gonadotropin-releasing Hormone Agonist Drugs market. The report also includes nautical information, where it shows Gonadotropin-releasing Hormone Agonist Drugs market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Gonadotropin-releasing Hormone Agonist Drugs market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Gonadotropin-releasing Hormone Agonist Drugs market.
Geographical Analysis:
Based on region, the global Gonadotropin-releasing Hormone Agonist Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Gonadotropin-releasing Hormone Agonist Drugs market are
AbbVie
AstraZeneca
Ferring
TerSera Therapeutics
Takeda
LIVZON
Ipsen
Sanofi
Endo
Segment by Type
Leuprorelin
Goserelin
Taltirelin
Histrelin
Other
Segment by Application
Hospital
Pharmacy
Other
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Gonadotropin-releasing Hormone Agonist Drugs market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Gonadotropin-releasing Hormone Agonist Drugs market.
• The market share of the global Gonadotropin-releasing Hormone Agonist Drugs market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Gonadotropin-releasing Hormone Agonist Drugs market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Gonadotropin-releasing Hormone Agonist Drugs market.
1 Gonadotropin-releasing Hormone Agonist Drugs Market Overview
1.1 Gonadotropin-releasing Hormone Agonist Drugs Product Scope
1.2 Gonadotropin-releasing Hormone Agonist Drugs Segment by Type
1.2.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2020-2026)
1.2.2 Leuprorelin
1.2.3 Goserelin
1.2.4 Taltirelin
1.2.5 Histrelin
1.2.6 Other
1.3 Gonadotropin-releasing Hormone Agonist Drugs Segment by Application
1.3.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Gonadotropin-releasing Hormone Agonist Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Gonadotropin-releasing Hormone Agonist Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Gonadotropin-releasing Hormone Agonist Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Gonadotropin-releasing Hormone Agonist Drugs Industry
1.5.1.1 Gonadotropin-releasing Hormone Agonist Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Gonadotropin-releasing Hormone Agonist Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Gonadotropin-releasing Hormone Agonist Drugs Players to Combat Covid-19 Impact
2 Gonadotropin-releasing Hormone Agonist Drugs Estimate and Forecast by Region
2.1 Global Gonadotropin-releasing Hormone Agonist Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Gonadotropin-releasing Hormone Agonist Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Gonadotropin-releasing Hormone Agonist Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Gonadotropin-releasing Hormone Agonist Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Gonadotropin-releasing Hormone Agonist Drugs Estimates and Projections (2015-2026)
2.4.3 China Gonadotropin-releasing Hormone Agonist Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Gonadotropin-releasing Hormone Agonist Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Estimates and Projections (2015-2026)
2.4.6 India Gonadotropin-releasing Hormone Agonist Drugs Estimates and Projections (2015-2026)
3 Global Gonadotropin-releasing Hormone Agonist Drugs Competition Landscape by Players
3.1 Global Top Gonadotropin-releasing Hormone Agonist Drugs Players by Sales (2015-2020)
3.2 Global Top Gonadotropin-releasing Hormone Agonist Drugs Players by Revenue (2015-2020)
3.3 Global Gonadotropin-releasing Hormone Agonist Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gonadotropin-releasing Hormone Agonist Drugs as of 2019)
3.4 Global Gonadotropin-releasing Hormone Agonist Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Gonadotropin-releasing Hormone Agonist Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Gonadotropin-releasing Hormone Agonist Drugs Players (Opinion Leaders)
4 Global Gonadotropin-releasing Hormone Agonist Drugs Market Size by Type
4.1 Global Gonadotropin-releasing Hormone Agonist Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Gonadotropin-releasing Hormone Agonist Drugs Price by Type (2014-2020)
4.2 Global Gonadotropin-releasing Hormone Agonist Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Gonadotropin-releasing Hormone Agonist Drugs Price Forecast by Type (2021-2026)
5 Global Gonadotropin-releasing Hormone Agonist Drugs Market Size by Application
5.1 Global Gonadotropin-releasing Hormone Agonist Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Gonadotropin-releasing Hormone Agonist Drugs Price by Application (2015-2020)
5.2 Global Gonadotropin-releasing Hormone Agonist Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Gonadotropin-releasing Hormone Agonist Drugs Price Forecast by Application (2021-2026)
3 North America Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures
3.2 North America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Company (2015-2020)
3.3 North America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2015-2020)
3.4 North America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2015-2020)
4 Europe Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures
4.2 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2015-2020)
5 China Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures
5.2 China Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Company (2015-2020)
5.3 China Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2015-2020)
5.4 China Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2015-2020)
6 Japan Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures
6.2 Japan Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2015-2020)
7 Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures
7.2 Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2015-2020)
8 India Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures
8.2 India Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Company (2015-2020)
8.3 India Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2015-2020)
8.4 India Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Gonadotropin-releasing Hormone Agonist Drugs Business
12.1 AbbVie
12.1.1 AbbVie Gonadotropin-releasing Hormone Agonist Drugs Corporation Information
12.1.2 AbbVie Gonadotropin-releasing Hormone Agonist Drugs Business Overview and Total Revenue
12.1.3 AbbVie Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AbbVie Gonadotropin-releasing Hormone Agonist Drugs Products Offered
12.1.5 AbbVie Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Corporation Information
12.2.2 AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Business Overview and Total Revenue
12.2.3 AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Products Offered
12.2.5 AstraZeneca Recent Development
12.3 Ferring
12.3.1 Ferring Gonadotropin-releasing Hormone Agonist Drugs Corporation Information
12.3.2 Ferring Gonadotropin-releasing Hormone Agonist Drugs Business Overview and Total Revenue
12.3.3 Ferring Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Ferring Gonadotropin-releasing Hormone Agonist Drugs Products Offered
12.3.5 Ferring Recent Development
12.4 TerSera Therapeutics
12.4.1 TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Corporation Information
12.4.2 TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Business Overview and Total Revenue
12.4.3 TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Products Offered
12.4.5 TerSera Therapeutics Recent Development
12.5 Takeda
12.5.1 Takeda Gonadotropin-releasing Hormone Agonist Drugs Corporation Information
12.5.2 Takeda Gonadotropin-releasing Hormone Agonist Drugs Business Overview and Total Revenue
12.5.3 Takeda Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Takeda Gonadotropin-releasing Hormone Agonist Drugs Products Offered
12.5.5 Takeda Recent Development
12.6 LIVZON
12.6.1 LIVZON Gonadotropin-releasing Hormone Agonist Drugs Corporation Information
12.6.2 LIVZON Gonadotropin-releasing Hormone Agonist Drugs Business Overview and Total Revenue
12.6.3 LIVZON Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 LIVZON Gonadotropin-releasing Hormone Agonist Drugs Products Offered
12.6.5 LIVZON Recent Development
12.7 Ipsen
12.7.1 Ipsen Gonadotropin-releasing Hormone Agonist Drugs Corporation Information
12.7.2 Ipsen Gonadotropin-releasing Hormone Agonist Drugs Business Overview and Total Revenue
12.7.3 Ipsen Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Ipsen Gonadotropin-releasing Hormone Agonist Drugs Products Offered
12.7.5 Ipsen Recent Development
12.8 Sanofi
12.8.1 Sanofi Gonadotropin-releasing Hormone Agonist Drugs Corporation Information
12.8.2 Sanofi Gonadotropin-releasing Hormone Agonist Drugs Business Overview and Total Revenue
12.8.3 Sanofi Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Sanofi Gonadotropin-releasing Hormone Agonist Drugs Products Offered
12.8.5 Sanofi Recent Development
12.9 Endo
12.9.1 Endo Gonadotropin-releasing Hormone Agonist Drugs Corporation Information
12.9.2 Endo Gonadotropin-releasing Hormone Agonist Drugs Business Overview and Total Revenue
12.9.3 Endo Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Endo Gonadotropin-releasing Hormone Agonist Drugs Products Offered
12.9.5 Endo Recent Development
13 Gonadotropin-releasing Hormone Agonist Drugs Manufacturing Cost Analysis
13.1 Gonadotropin-releasing Hormone Agonist Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Gonadotropin-releasing Hormone Agonist Drugs
13.4 Gonadotropin-releasing Hormone Agonist Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Gonadotropin-releasing Hormone Agonist Drugs Distributors List
14.3 Gonadotropin-releasing Hormone Agonist Drugs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Gonadotropin-releasing Hormone Agonist Drugs Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Gonadotropin-releasing Hormone Agonist Drugs Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Gonadotropin-releasing Hormone Agonist Drugs Players to Combat Covid-19 Impact
Table 8. Global Market Gonadotropin-releasing Hormone Agonist Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Region (2015-2020)
Table 10. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Region (2015-2020)
Table 11. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Share by Region (2015-2020)
Table 13. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Share Forecast by Region (2021-2026)
Table 17. Global Gonadotropin-releasing Hormone Agonist Drugs (K Units) of Key Companies (2015-2020)
Table 18. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Share by Company (2015-2020)
Table 19. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Share by Company (2015-2020)
Table 21. Global Gonadotropin-releasing Hormone Agonist Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gonadotropin-releasing Hormone Agonist Drugs as of 2019)
Table 22. Global Gonadotropin-releasing Hormone Agonist Drugs Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Gonadotropin-releasing Hormone Agonist Drugs Manufacturing Sites and Area Served
Table 24. Manufacturers Gonadotropin-releasing Hormone Agonist Drugs Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Gonadotropin-releasing Hormone Agonist Drugs Players
Table 27. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Type (2015-2020)
Table 28. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Share by Type (2015-2020)
Table 29. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Gonadotropin-releasing Hormone Agonist Drugs Price (K Units) by Type (2015-2020)
Table 31. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Share by Type (2021-2026)
Table 32. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Share by Type (2021-2026)
Table 34. Global Gonadotropin-releasing Hormone Agonist Drugs Price (K Units) by Type (2021-2026)
Table 35. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Application (2015-2020)
Table 36. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Share by Application (2015-2020)
Table 37. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Gonadotropin-releasing Hormone Agonist Drugs Price (K Units) by Application (2015-2020)
Table 39. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Application (2021-2026)
Table 40. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Share by Application (2021-2026)
Table 41. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Share by Application (2021-2026)
Table 43. Global Gonadotropin-releasing Hormone Agonist Drugs Price (K Units) by Application (2021-2026)
Table 44. United States Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Company (2015-2020)
Table 45. United States Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Company (2015-2020)
Table 46. United States Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Type (2015-2020)
Table 47. United States Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2015-2020)
Table 48. United States Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Application (2015-2020)
Table 49. United States Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2015-2020)
Table 50. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Company (2015-2020)
Table 51. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Company (2015-2020)
Table 52. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Type (2015-2020)
Table 53. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Application (2015-2020)
Table 55. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2015-2020)
Table 56. China Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Company (2015-2020)
Table 57. China Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Company (2015-2020)
Table 58. China Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Type (2015-2020)
Table 59. China Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2015-2020)
Table 60. China Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Application (2015-2020)
Table 61. China Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2015-2020)
Table 62. Japan Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Company (2015-2020)
Table 63. Japan Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Company (2015-2020)
Table 64. Japan Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Type (2015-2020)
Table 65. Japan Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2015-2020)
Table 66. Japan Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Application (2015-2020)
Table 67. Japan Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2015-2020)
Table 74. India Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Company (2015-2020)
Table 75. India Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Company (2015-2020)
Table 76. India Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Type (2015-2020)
Table 77. India Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2015-2020)
Table 78. India Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Application (2015-2020)
Table 79. India Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2015-2020)
Table 80. AbbVie Corporation Information
Table 81. AbbVie Description and Business Overview
Table 82. AbbVie Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. AbbVie Gonadotropin-releasing Hormone Agonist Drugs Product
Table 84. AbbVie Recent Development
Table 85. AstraZeneca Corporation Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Product
Table 89. AstraZeneca Recent Development
Table 90. Ferring Corporation Information
Table 91. Ferring Description and Business Overview
Table 92. Ferring Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Ferring Gonadotropin-releasing Hormone Agonist Drugs Product
Table 94. Ferring Recent Development
Table 95. TerSera Therapeutics Corporation Information
Table 96. TerSera Therapeutics Description and Business Overview
Table 97. TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Product
Table 99. TerSera Therapeutics Recent Development
Table 100. Takeda Corporation Information
Table 101. Takeda Description and Business Overview
Table 102. Takeda Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Takeda Gonadotropin-releasing Hormone Agonist Drugs Product
Table 104. Takeda Recent Development
Table 105. LIVZON Corporation Information
Table 106. LIVZON Description and Business Overview
Table 107. LIVZON Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. LIVZON Gonadotropin-releasing Hormone Agonist Drugs Product
Table 109. LIVZON Recent Development
Table 110. Ipsen Corporation Information
Table 111. Ipsen Description and Business Overview
Table 112. Ipsen Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Ipsen Gonadotropin-releasing Hormone Agonist Drugs Product
Table 114. Ipsen Recent Development
Table 115. Sanofi Corporation Information
Table 116. Sanofi Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Sanofi Description and Business Overview
Table 118. Sanofi Gonadotropin-releasing Hormone Agonist Drugs Product
Table 119. Sanofi Recent Development
Table . Endo Corporation Information
Table . Endo Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Endo Description and Business Overview
Table . Endo Gonadotropin-releasing Hormone Agonist Drugs Product
Table . Endo Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Gonadotropin-releasing Hormone Agonist Drugs Distributors List
Table 128. Gonadotropin-releasing Hormone Agonist Drugs Customers List
Table 129. Market Key Trends
Table 130. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 131. Key Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Gonadotropin-releasing Hormone Agonist Drugs Product Picture
Figure 2. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Gonadotropin-releasing Hormone Agonist Drugs Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Pharmacy Examples
Figure 8. Other Examples
Figure 9. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Gonadotropin-releasing Hormone Agonist Drugs Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Gonadotropin-releasing Hormone Agonist Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Gonadotropin-releasing Hormone Agonist Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Gonadotropin-releasing Hormone Agonist Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Gonadotropin-releasing Hormone Agonist Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Gonadotropin-releasing Hormone Agonist Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Gonadotropin-releasing Hormone Agonist Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Gonadotropin-releasing Hormone Agonist Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Gonadotropin-releasing Hormone Agonist Drugs Players Market Share by Revenue in Gonadotropin-releasing Hormone Agonist Drugs 2015 & 2019
Figure 27. Gonadotropin-releasing Hormone Agonist Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Share by Type (2015-2020)
Figure 29. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Share by Application (2015-2020)
Figure 31. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type in 2019
Figure 33. United States Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type in 2019
Figure 34. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Company in 2019
Figure 35. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type in 2019
Figure 36. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application in 2019
Figure 37. China Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Company in 2019
Figure 38. China Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type in 2019
Figure 39. China Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application in 2019
Figure 40. Japan Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Company in 2019
Figure 41. Japan Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type in 2019
Figure 42. Japan Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application in 2019
Figure 43. Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Company in 2019
Figure 44. Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type in 2019
Figure 45. Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application in 2019
Figure 46. India Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Company in 2019
Figure 47. India Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type in 2019
Figure 48. India Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application in 2019
Figure 49. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Ferring Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. TerSera Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. LIVZON Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Ipsen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Endo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Key Raw Materials Price Trend
Figure 59. Manufacturing Cost Structure of Gonadotropin-releasing Hormone Agonist Drugs
Figure 60. Manufacturing Process Analysis of Gonadotropin-releasing Hormone Agonist Drugs
Figure 61. Gonadotropin-releasing Hormone Agonist Drugs Industrial Chain Analysis
Figure 62. Channels of Distribution
Figure 63. Distributors Profiles
Figure 64. Porter's Five Forces Analysis
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
ゴナドトロピン放出ホルモン作用物質の世界市場レポート2020 A recently published report by QY Research titled Global Gonadotropin-releasing Hormone Agonist Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistical…- 黄体形成ホルモン放出ホルモン類似体薬の世界市場レポート2020 A recently published report by QY Research titled Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report als…
- ホルモン放出IUDの世界市場レポート2020 The hormone-releasing intrauterine device (IUD) is a small T-shaped device made of flexible plastic. It is inserted into the uterus, where it releases a low daily dose of a progestin hormone called levonorgestrel. Market Analysis and Insights: Global Hormone-releasing IUD Market The global Hormone-r…
- 黄体形成ホルモン放出ホルモン類似体の世界市場レポート2020 A recently published report by QY Research titled Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also stat…
- オピオイド作動薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Opioids Agonist Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.3% in the forecast period of 2020 to 2025 and will expected to reach USD 18590 million by 2025, from USD 16980 million in 2019. The Opioids Agonist …